Archive for the Category ‘Mid and Large Cap’

Introducing Revolutionary Cancer Immunotherapy While Redefining the Treatment for T1D, T2D (NASDAQ: GNBT)

Introducing Revolutionary Cancer Immunotherapy While Redefining the Treatment for T1D, T2D (NASDAQ: GNBT)

Generex Biotechnology Corporation
(Public, NASDAQ: GNBT)
This past year, small cap  biotech investors were witness to some of the most profitable gains ever recorded. The only way to encapsulate it would be through two simple words, “FDA Approval”. Yes, any company with high probability of approval on their blockbuster drugs saw their shares literally explode beyond technical [...]

Back to Top

Social Media Profiles

ADVERTISEMENT

Visa Master Card American Express Paypal

© Copyright 2009 - 2010 MiV Investments Inc. All Rights Reserved.

The Market Financial is a division of MiV Investments Inc., ON, Canada

Michael Vlaicu, Publisher